Since October 3, 2018, the Inselspital, University Hospital of Bern and the BloodCenter of Wisconsin as part of Versiti Wisconsin, Inc. are collaborating in support of the Hereditary TTP Registry Study.
This collaboration consists of diagnostic assessments that serve to confirm the diagnosis of congenital Thrombotic Thrombocytopenic Purpura (cTTP) in patients located in the USA. By doing so, we hope to increase the enrolment of cTTP patients from the USA into the Registry study. The long-term aim of the collaboration is to promote patient health for congenital Thrombotic Thrombocytopenic Purpura. The collaboration will support the Registry’s objective to gain understanding of this ultra-rare disease.
Are you a treating physician of a patient in the USA with suspected congenital TTP?
Is your patient interested in participating in the Registry study?
Please email to support@ttpregistry.net to find out more, and learn how you can benefit from this initiated collaboration with the Versiti, Inc.